NPI: 1043958473 · LAMBERTVILLE, MI 48144 · Urgent Care Clinic/Center · NPI assigned 05/25/2022
Authorized official MOLNAR, NANCY controls 20+ related entities in our dataset. Read more
| Authorized Official | MOLNAR, NANCY (BUSINESS OPERATIONS MANAGER) |
| NPI Enumeration Date | 05/25/2022 |
Other providers sharing the same authorized official: MOLNAR, NANCY
| Year | Claims | Total Paid |
|---|---|---|
| 2023 | 1,304 | $60K |
| 2024 | 1,688 | $70K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 611 | 611 | $39K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 330 | 330 | $31K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 541 | 505 | $29K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 187 | 184 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 408 | 394 | $5K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 148 | 143 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 249 | 122 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 62 | 62 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 81 | 80 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 38 | 38 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 12 | 12 | $793.20 |
| 87428 | 33 | 31 | $691.74 | |
| 99000 | 279 | 270 | $42.05 | |
| 81002 | 13 | 13 | $37.44 |